Johnson & Johnson JNJ
NYSE JNJ
$267.67 -5.77 (-2.11%)
At close: Aug 20, 2026 · 4:00 PM EDT

Johnson & Johnson (JNJ) Interest & Investment Income (2009 - 2026)

Johnson & Johnson (JNJ) posted Interest & Investment Income of $219.0 million for Q2 2026, down 4.37% sequentially from $229.0 million in Q1 2026, and down 15.77% YoY from $260.0 million in Q2 2025.

Johnson & Johnson (JNJ) Interest & Investment Income (2009 - 2026) Analysis & Trends

Johnson & Johnson has reported Interest & Investment Income for 18 years, with the latest figure at $219.0 million in Q2 2026.

  • Quarterly Interest & Investment Income fell 15.77% year-over-year to $219.0 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $912.0 million (down 21.72% YoY) and the FY2025 annual result came in at $1.1 billion, down 20.72% from the prior year.
  • Interest & Investment Income declined to $219.0 million in Q2 2026 per JNJ's latest filing, from $229.0 million in the prior quarter.
  • Over five years, Interest & Investment Income peaked at $450.0 million in Q1 2023 and troughed at $22.0 million in Q2 2022.
  • A 5-year average of $265.7 million and a median of $270.5 million in 2024 frame the typical range for Interest & Investment Income.
  • The sharpest annual moves came in 2022 and 2025: Interest & Investment Income jumped 1053.85% in 2022, then tumbled 34.18% in 2025.
  • Over 5 years, Interest & Investment Income stood at $150.0 million in 2022, then surged by 142.0% to $363.0 million in 2023, then fell by 22.59% to $281.0 million in 2024, then declined by 15.66% to $237.0 million in 2025, then declined by 7.59% to $219.0 million in 2026.
  • According to Business Quant data, Interest & Investment Income over the past three periods registered $219.0 million, $229.0 million, and $237.0 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Int & Inv Inc (Qtr)
1 Johnson & Johnson 645.88 Bn 625.12 Bn 17.26 Bn 219.00 Mn
2 AbbVie 463.46 Bn 456.89 Bn 12.70 Bn -679.00 Mn
3 Merck 367.92 Bn 360.78 Bn 12.21 Bn -
4 Novartis Ag 297.71 Bn 290.02 Bn 11.24 Bn -
5 Astrazeneca 255.55 Bn 250.65 Bn 12.86 Bn 80.00 Mn
6 Amgen 234.52 Bn 220.53 Bn 7.24 Bn -
7 Gilead Sciences 178.22 Bn 175.04 Bn 6.22 Bn -
8 Pfizer 158.57 Bn 146.88 Bn 10.94 Bn -
9 Gsk 105.32 Bn 101.15 Bn 8.24 Bn 77.82 Mn
10 Sanofi 54.20 Bn 46.82 Bn 10.79 Bn 89.50 Mn

Historic Data

Download Data
DateValue
Jun 28, 2026 219.00 Mn
Mar 29, 2026 229.00 Mn
Dec 28, 2025 237.00 Mn
Sep 28, 2025 227.00 Mn
Jun 29, 2025 260.00 Mn
Mar 30, 2025 332.00 Mn
Dec 29, 2024 281.00 Mn
Sep 29, 2024 292.00 Mn
Jun 30, 2024 395.00 Mn
Mar 31, 2024 364.00 Mn
Dec 31, 2023 363.00 Mn
Oct 1, 2023 374.00 Mn
Jul 2, 2023 326.00 Mn
Apr 2, 2023 198.00 Mn
Jan 1, 2023 450.00 Mn
Oct 2, 2022 150.00 Mn
Jul 3, 2022 64.00 Mn
Apr 3, 2022 22.00 Mn
Oct 3, 2021 13.00 Mn
Jul 4, 2021 12.00 Mn